InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 43141

Saturday, 03/10/2018 2:47:47 PM

Saturday, March 10, 2018 2:47:47 PM

Post# of 48316
I don't believe the CEO of Oncosec is lying to Oncosec shareholders. He said that the 23 mil equity raise was to sponsor a TNBC combination phase II trial with checkpoint therapy. 2 patients of the 5 in the pilot study were given Opdivo as following treatment so it is likely the collaboration in a phase II trial will be with Bristol Myers. Good times are ahead for Oncosec and shareholders. Good luck to you and all holders of Oncosec shares. Looking great this year. I am very excited.